Neuroendocrine neoplasia and bone (Review).
Ghemigian A, Carsote M, Sandru F, Petca RC, Oproiu AM, Petca A, Valea A.
Exp Ther Med. 2021 Nov;22(5):1219. doi: 10.3892/etm.2021.10653. Epub 2021 Aug 26.
Cortisol secretion and abnormalities of glucose metabolism in nondiabetic patients with hypertension.
Brosolo G, Da Porto A, Bulfone L, Vacca A, Bertin N, Catena C, Sechi LA.
J Hypertens. 2024 Feb 1;42(2):227-235. doi: 10.1097/HJH.0000000000003590. Epub 2023 Oct 5.
Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome.
Krsek M, Silha JV, Jezková J, Hána V, Marek J, Weiss V, Stepán JJ, Murphy LJ.
Clin Endocrinol (Oxf). 2004 Mar;60(3):350-7. doi: 10.1111/j.1365-2265.2003.01987.x.
The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
Regazzo D, Barbot M, Scaroni C, Albiger N, Occhi G.
Rev Endocr Metab Disord. 2020 Mar;21(1):165-183. doi: 10.1007/s11154-019-09536-6.
Cardio-metabolic consequences of glucocorticoid replacement: relevance of ultradian signalling.
Henley DE, Lightman SL.
Clin Endocrinol (Oxf). 2014 May;80(5):621-8. doi: 10.1111/cen.12422. Epub 2014 Feb 25.
Glucose transport in the equine hoof.
Asplin KE, Curlewis JD, McGowan CM, Pollitt CC, Sillence MN.
Equine Vet J. 2011 Mar;43(2):196-201. doi: 10.1111/j.2042-3306.2010.00127.x.
Relationship between type 2 diabetes mellitus and hypothalamic-pituitary-adrenal axis.
Felšöci M, Schroner Z, Petrovičová J, Lazúrová I.
Wien Klin Wochenschr. 2011 Jan;123(1-2):28-33. doi: 10.1007/s00508-010-1497-8. Epub 2010 Dec 20.
[Diabetes and prediabetes in endocrine disorders].
Krysiak R, Rudzki H, Okopień B.
Wiad Lek. 2012;65(3):187-98.
Glucocorticoid modulates oxidative and thermogenic function of rat brown adipose tissue and human brown adipocytes.
Bolin AP, de Fatima Silva F, Salgueiro RB, Dos Santos BA, Komino ACM, Andreotti S, de Sousa É, de Castro É, Real CC, de Paula Faria D, Souza GP, Camara H, Sorgi CA, Tseng YH, Lima FB, Rodrigues AC.
J Cell Physiol. 2024 Aug 1:e31397. doi: 10.1002/jcp.31397. Online ahead of print.
Disrupting hypothalamic glucocorticoid receptors causes HPA axis hyperactivity and excess adiposity.
Laryea G, Schütz G, Muglia LJ.
Mol Endocrinol. 2013 Oct;27(10):1655-65. doi: 10.1210/me.2013-1187. Epub 2013 Aug 26.
